본문 바로가기
통합검색 바로가기
메인메뉴 바로가기
화면컨트롤메뉴
인쇄하기

영문뉴스

Boryung Pharmaceutical: Ascending from Chungcheongnam-do Province to the Global Stage

The establishment of a cutting-edge “Smart Factory”

2019.06.27(목) 09:51:10 | CNnews (이메일주소:chungnamdo@korea.kr
               	chungnamdo@korea.kr)

Boryung Pharmaceutical’s Smart Factory

▲ Boryung Pharmaceutical’s Smart Factory



Korea’s leading pharmaceutical corporation, Boryung Pharmaceutical established a cutting-edge manufacturing complex in Yesan, Chungcheongnam-do Province and began operations there. According to the province, the opening of the new manufacturing complex took place on April 23rd with 200 company-related officials in attendance.  
 

For this new manufacturing complex which is located in the Junggok Industrial Complex, in Eungbong-myeon, the company has invested KRW 160 billion into a plot of land that is 145,097㎡ in size taking two years in total to complete the project. This complex is 28551㎡ in size, including both manufacturing and support sections.

There are facilities built for solid drug and anticancer injection manufacturing. The new complex is a smart factory that has automated manufacturing, packaging, and delivery systems which can produce a total of 870 million pills and six million anticancer shots annually. The factory can also process 4000 units of product, which is three times more than the existing factory in Ansan.  
 

With the establishment of the new manufacturing complex in Yesan serving as the central power through which the brand plans to expand globally, Boryung Pharmaceutical expects to increase the quantity of their exports of main products, like the Canave Family. Additionally, by taking a step further and increasing their competitive edge in the field of anticancer drugs, domestically and abroad, the company is expected to grow and become a global force.  
 

Along with the anticancer drugs that are in development, Boryung Pharmaceuticals also set aside specific manufacturing facilities for anticancer and cancer-treating drugs, as well as the immunocyte-repairing drugs produced by the company’s affiliate Vigencell, at the new Yesan complex, proving that they are ready to ascend to the global stage. The new Yesan complex employ 190 people and has the goal of achieving KRW 52 billion in sales.

Chungcheongnam-do Province hopes that the new Yesan manufacturing complex will attract related facilities to the area, thanks to its location near the highway between Dangjin and Daejeon, the Yesan-Sudeoksa IC, the Dangjin and Pyeongtaek Ports for shipment, and the new town of Naepo.

 

CNnews님의 다른 기사 보기

제4유형
본 저작물은 "공공누리" 제4유형:출처표시+상업적 이용금지+변경금지조건에 따라 이용 할 수 있습니다.
댓글 작성 폼

댓글작성

충남넷 카카오톡 네이버

* 충청남도 홈페이지 또는 SNS사이트에 로그인 후 작성이 가능합니다.

불건전 댓글에 대해서 사전통보없이 관리자에 의해 삭제될 수 있습니다.